Irinotecan ONCO
Irinotecan
ATX: L01CE02
Pharmacological group: Plant alkaloids and other natural products - Topoisomerase 1 (TOP1) inhibitors
Drug form: Concentrate for solution for infusion
Dosage and pack size: 40 mg/2ml; 100mg/5ml; 150mg/7,5 ml; 230mg/11,5ml; 300mg/15ml in vials in package №1
Indication: Metastatic carcinoma of the colon or rectum as first-line treatment in combination with fluorouracil and leucovorin